Loading clinical trials...
Loading clinical trials...
CD19-directed CAR-T Cell Therapy for Refractory or Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma: a Multicenter Phase I/II Trial.
Conditions
Interventions
CART-19
Locations
5
Brazil
Hospital de Clínicas da UNICAMP
Campinas, São Paulo, Brazil
Ribeirao Preto School of Medicine, University of Sao Paulo
Ribeirão Preto, São Paulo, Brazil
Hospital Sírio-Libanês
São Paulo, São Paulo, Brazil
Hospital das Clinicas de São Paulo
São Paulo, São Paulo, Brazil
A Beneficência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil
Start Date
March 21, 2024
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2028
Last Updated
December 9, 2024
NCT04307576
NCT06510361
NCT05442515
NCT07162181
NCT06528301
NCT06855810
Lead Sponsor
University of Sao Paulo
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions